Compliance & Validation — Documented
HIPAA, SOC 2 Type II
ConcertAI
Real-world data and AI SaaS for oncology clinical development and research.
ConcertAI provides real-world data and AI software for life sciences, with a focus on oncology and other specialty areas. Its platforms support patient cohort identification, trial feasibility and site selection, and research analytics using curated clinical, genomic, and outcomes data drawn from provider networks.
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Compliance
- HIPAA, SOC 2 Type II
- Deployment options
- cloud
- Website
- https://www.concertai.com
- https://www.linkedin.com/company/17459
Categories
AI Use Cases
- Patient Identification & Segmentation
- Patient Recruitment & Enrollment
- Site Selection & Performance
Vendor Scorecard
93% — Complete coverage. Coverage score — how completely Atlas documents ConcertAI across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Documented
Annual data + platform license
Implementation & Onboarding — Documented
3–6 months
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, R&D Leadership, Commercial, Data Management
Solution Scope — Documented
Natural Language Processing, Real-World Evidence
Company Viability — Partially documented
Private, Founded 2017
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Evidence & Outcomes
Five-year real-world evidence research collaboration with the U.S. FDA in oncology
ConcertAI entered a five-year collaborative research program with the U.S. FDA, 'Evaluation of Real-World Outcomes and Safety in the Treatment of Cancer,' applying its oncology real-world data and AI to derive real-world evidence across a range of clinical and regulatory use cases.
press release (ConcertAI (PR Newswire)) · 2021-06-15 — Partner: U.S. FDA
Questions to Ask This Vendor
- How deep is your oncology real-world data in our indication?
- How does your platform support site feasibility analysis?
- How are data curation and quality controlled?